Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Jan 27, 2016
Insider Transaction Report
Form 4
MYERS STEVEN S
Director
Transactions
- Award
Options to Purchase Common Stock
2016-01-25+15,000→ 15,000 totalExercise: $0.63From: 2017-01-25Exp: 2026-01-25→ Common Stock (15,000 underlying) - Award
Common Stock
2016-01-25+9,000→ 311,931 total
Holdings
- 84,331(indirect: By IRA)
Common Stock
- 19,531(indirect: By Trust)
Common Stock
- 8,012(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents 9,000 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan. The shares restricted stock will all vest on January 25, 2017.
- [F2]Includes 9,000 shares of unvested restricted stock.